A broad amplification pattern at 3q in squamous cell lung cancer - A fluorescence in situ hybridization study

Cancer Genetics and Cytogenetics

Volumn 117, Issue 1, 2000, Pages 66-70

  Kettunen, Eeva ^a   El Rifai, Wa'El ^a   Björkqvist, Anna Maria ^a   Wolff, Henrik ^b   Karjalainen, Antti ^b   Anttila, Sisko ^b   Mattson, Karin ^c   Husgafvel Pursiainen, Kirsti ^b   Knuutila, Sakari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c Div Pulmon Dis Clin Physiol   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 3Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CENTROMERE; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS;

EID: 0033955454     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00146-6     Document Type: Article

References (26)

1. Testa J.R., Liu Z., Feder M., Bell D.W., Balsara B., Cheng J.Q., Taguchi T. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet. 95:1997;20-32.
2. Balsara B.R., Sonoda G., du Manoir S., Siegfried J.M., Gabrielson E., Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overpresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57:1997;2116-2120.
3. Petersen I., Bujard M., Petersen S., Wolf G., Goeze A., Schwendel A., Langreck H., Gellert K., Reichel M., Just K., du Manoir S., Cremer T., Dietel M., Ried T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 57:1997;2331-2335.
4. Sozzi G., Veronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Ohta M., Huebner K., Croce C.M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell. 85:1996;17-26.
5. Fong K.M., Biesterveld E.J., Virmani A., Wistuba I., Sekido Y., Bader S.A., Ahmadian M., Ong S.T., Rassool F.V., Zimmerman P.V., Giaccone G., Gazdar A.F., Minna J.D. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 57:1997;2256-2267.
6. Björkqvist A.-M., Husgafvel-Pursiainen K., Anttila S., Karjalainen A., Tammilehto L., Mattson K., Vainio H., Knuutila S. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosom Cancer. 22:1998;79-82.
7. Brass N., Ukena I., Remberger K., Mack U., Sybrecht G.W., Meese E.U. DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer. 32A:1996;1205-1208.
8. Sato S., Nakamura Y., Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 54:1994;5652-5655.
9. Feder M., Siegfried J.M., Balshem A., Litwin S., Keller S.M., Liu Z., Testa J.R. Clinical relevance of chromosome abnormalities in non-small cell lung cancer. Cancer Genet Cytogenet. 102:1998;25-31.
10. Knuutila S., Björkqvist A.-M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai We Hemmer S., Wasenius V.-M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Am J Pathol. 152:1998;1107-1123.
11. Sobin L.H., Fleming I.D. TNM classification of malignant tumors, 5th Ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 80:1997;1803-1804.
12. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
13. Hyytinen E., Visakorpi T., Kallioniemi A., Kallioniemi O.-P., Isola J. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry. 16:1994;93-99.
14. Hoffman C.S., Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene. 57:1987;267-272.
15. Knuutila S. Morphology antibody chromosome technique for determining phenotype and genotype of the same cell. Preparation of tissue sections. Dracopoli N.C., Haines J.L., Korf B.R., Moir D.T., Morton C.C., Seidman C.E., Seidman J.G., Smith D.R. Current Protocols in Human Genetics, Vol. 1. 1994;4 John Wiley & Sons, Inc, New York. 7.22-4.7.23.
16. Pinkel D., Straume T., Gray J.W. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA. 83:1986;2934-2938.
17. Brass N., Racz A., Heckel D., Remberger K., Sybrecht G.W., Meese E.U. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res. 57:1997;2290-2294.
18. Soder A.I., Hoare S.F., Muir S., Going J.J., Parkonson K., Keith W.N. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene. 14:1997;1013-1021.
19. Soder A.I., Going J.J., Kaye S.B., Keith W.N. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene. 16:1998;979-983.
20. Brass N., Heckel D., Sahin U., Pfreundschuh M., Sybrecht G.W., Meese E. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet. 6:1997;33-39.
21. Takai S., Long J.E., Yamada K., Miki T. Chromosomal localization of the human ECT2 proto-oncogene to 3q26.1-q26.2 by somatic cell analysis and fluorescence in situ hybridization. Genomics. 27:1995;220-222.
22. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genet. 21:1999;99-102.
23. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer. 10:1994;231-243.
24. Testa J.R., Siegfried J.M., Liu Z., Hunt J.D., Feder M.M., Litwin S., Zhou J.Y., Taguchi T., Keller S.M. Cytogenetic analysis of 63 non-small cell lung carcinomas. recurrent chromosome alterations amid frequent and widespread genomic upheaval Genes Chromosom Cancer. 11:1994;178-194.
25. Nielsen J.L., Walsh J.T., Degen D.R., Drabek S.M., McGill J.R., Von Hoff D.D. Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer. Cancer Genet Cytogenet. 65:1993;120-124.
26. Monni O., Oinonen R., Elonen E., Franssila K., Teerenhovi L., Joensuu H., Knuutila S. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosom Cancer. 21:1998;298-307.